Designing a Placebo Microneedle Stamp: Modeling and Validation in a Clinical Control Trial

Recently, several clinical studies have been conducted using microneedles (MNs), and various devices have been developed. This study aimed to propose and confirm the feasibility of a placebo control for activating MN clinical research. A 0.5 mm MN stamp with 42 needles was used as a treatment interv...

Full description

Bibliographic Details
Main Authors: Seung-Yeon Jeong, Ye-Seul Lee, Ji-Yeun Park, Jung-Hwan Park, Hi-Joon Park, Song-Yi Kim
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/3/395
_version_ 1797239651481681920
author Seung-Yeon Jeong
Ye-Seul Lee
Ji-Yeun Park
Jung-Hwan Park
Hi-Joon Park
Song-Yi Kim
author_facet Seung-Yeon Jeong
Ye-Seul Lee
Ji-Yeun Park
Jung-Hwan Park
Hi-Joon Park
Song-Yi Kim
author_sort Seung-Yeon Jeong
collection DOAJ
description Recently, several clinical studies have been conducted using microneedles (MNs), and various devices have been developed. This study aimed to propose and confirm the feasibility of a placebo control for activating MN clinical research. A 0.5 mm MN stamp with 42 needles was used as a treatment intervention, and a placebo stamp with four acupressure-type needles that did not penetrate was proposed and designed as a control for comparison. First, to check whether the placebo stamp did not invade the skin and to set an appropriate level of pressure to be provided during skin stimulation, two participants were stimulated with five different forces on the forearm, and then the skin was dyed. Secondly, to evaluate the validity of the placebo control group, a blinded study between the MN and placebo stamps was performed on 15 participants. We confirmed that the placebo stamp did not penetrate the skin at any intensity or location. Both types of stamps reported relatively low pain levels, but the MN stamp induced higher pain compared to the placebo stamp. Based on the speculation regarding the type of intervention received, the MN stamp was successfully blinded (random guess), whereas the placebo stamp was unblinded. However, according to a subgroup analysis, it was confirmed that the group with low skin sensitivity was completely blind. Blinding the placebo MN stamp had limited success in participants with low skin sensitivity. Future research on suitable placebo controls, considering the variations in MN stamp length and needle count, is warranted.
first_indexed 2024-04-24T17:54:56Z
format Article
id doaj.art-4bd2032c5c5e498db80357fc95be4a34
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-04-24T17:54:56Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-4bd2032c5c5e498db80357fc95be4a342024-03-27T13:59:48ZengMDPI AGPharmaceutics1999-49232024-03-0116339510.3390/pharmaceutics16030395Designing a Placebo Microneedle Stamp: Modeling and Validation in a Clinical Control TrialSeung-Yeon Jeong0Ye-Seul Lee1Ji-Yeun Park2Jung-Hwan Park3Hi-Joon Park4Song-Yi Kim5Department of Anatomy and Acupoint, College of Korean Medicine, Gachon University, Seongnam 13120, Republic of KoreaJaseng Spine and Joint Research Institute, Jaseng Medical Foundation, Seoul 06110, Republic of KoreaDepartment of Meridian & Acupoint, College of Korean Medicine, Daejeon University, Daejeon 34141, Republic of KoreaDepartment of BioNano Technology, Gachon BioNano Research Institute, Gachon University, Seongnam 13120, Republic of KoreaAcupuncture and Meridian Science Research Center (AMSRC), Kyung Hee University, Dongdaemun-gu, Seoul 02447, Republic of KoreaDepartment of Anatomy and Acupoint, College of Korean Medicine, Gachon University, Seongnam 13120, Republic of KoreaRecently, several clinical studies have been conducted using microneedles (MNs), and various devices have been developed. This study aimed to propose and confirm the feasibility of a placebo control for activating MN clinical research. A 0.5 mm MN stamp with 42 needles was used as a treatment intervention, and a placebo stamp with four acupressure-type needles that did not penetrate was proposed and designed as a control for comparison. First, to check whether the placebo stamp did not invade the skin and to set an appropriate level of pressure to be provided during skin stimulation, two participants were stimulated with five different forces on the forearm, and then the skin was dyed. Secondly, to evaluate the validity of the placebo control group, a blinded study between the MN and placebo stamps was performed on 15 participants. We confirmed that the placebo stamp did not penetrate the skin at any intensity or location. Both types of stamps reported relatively low pain levels, but the MN stamp induced higher pain compared to the placebo stamp. Based on the speculation regarding the type of intervention received, the MN stamp was successfully blinded (random guess), whereas the placebo stamp was unblinded. However, according to a subgroup analysis, it was confirmed that the group with low skin sensitivity was completely blind. Blinding the placebo MN stamp had limited success in participants with low skin sensitivity. Future research on suitable placebo controls, considering the variations in MN stamp length and needle count, is warranted.https://www.mdpi.com/1999-4923/16/3/395microneedlesplacebosham controldrug deliveryacupuncture
spellingShingle Seung-Yeon Jeong
Ye-Seul Lee
Ji-Yeun Park
Jung-Hwan Park
Hi-Joon Park
Song-Yi Kim
Designing a Placebo Microneedle Stamp: Modeling and Validation in a Clinical Control Trial
Pharmaceutics
microneedles
placebo
sham control
drug delivery
acupuncture
title Designing a Placebo Microneedle Stamp: Modeling and Validation in a Clinical Control Trial
title_full Designing a Placebo Microneedle Stamp: Modeling and Validation in a Clinical Control Trial
title_fullStr Designing a Placebo Microneedle Stamp: Modeling and Validation in a Clinical Control Trial
title_full_unstemmed Designing a Placebo Microneedle Stamp: Modeling and Validation in a Clinical Control Trial
title_short Designing a Placebo Microneedle Stamp: Modeling and Validation in a Clinical Control Trial
title_sort designing a placebo microneedle stamp modeling and validation in a clinical control trial
topic microneedles
placebo
sham control
drug delivery
acupuncture
url https://www.mdpi.com/1999-4923/16/3/395
work_keys_str_mv AT seungyeonjeong designingaplacebomicroneedlestampmodelingandvalidationinaclinicalcontroltrial
AT yeseullee designingaplacebomicroneedlestampmodelingandvalidationinaclinicalcontroltrial
AT jiyeunpark designingaplacebomicroneedlestampmodelingandvalidationinaclinicalcontroltrial
AT junghwanpark designingaplacebomicroneedlestampmodelingandvalidationinaclinicalcontroltrial
AT hijoonpark designingaplacebomicroneedlestampmodelingandvalidationinaclinicalcontroltrial
AT songyikim designingaplacebomicroneedlestampmodelingandvalidationinaclinicalcontroltrial